Eicosis Human Health Inc.

This study tests an experimental oral drug called EC5026 in 18 adults with Parkinson's disease. The main goal is to check if the drug is safe and how it works in the body. Researchers will also look for signs that it might improve symptoms, though that is not the primary focus. P…

This early-stage trial tests a new drug called EC5026 for nerve pain caused by spinal cord injury. About 36 adults with this type of pain will take either the drug or a placebo daily for 14 days. The main goal is to check if the drug is safe and tolerable, while also seeing if it…